Literature DB >> 9018337

Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines.

M M Webber1, D Bello, S Quader.   

Abstract

This is Part 2 of a three-part review and deals with tumorigenic cell lines. Several immortalized and malignant adult human prostatic epithelial cell lines have been recently developed. The three most widely used carcinoma cell lines-DU-145, PC-3, and LNCaP-developed between 1977 and 1980, have greatly contributed to our current understanding of prostate cancer. Before a cell line can be accepted as having prostatic epithelial origin, some basic characteristics must be established. Expression of specific cytokeratins but absence of desmin and factor VIII should be first determined to establish epithelial origin. Responsiveness to androgens and expression of androgen receptor and prostate-specific antigen should be examined under stringent culture conditions to establish prostatic epithelial origin. Response to growth factors and expression of their receptors facilitates further characterization of cell behavior. Cell lines immortalized by human papillomaviruses (HPVs) are of special interest because HPVs are involved in a variety of anogenital cancers and may also play a role in prostate carcinogenesis. Malignant transformation of HPV-18 immortalized cells with the ras oncogene provides cell systems for investigating the multistep process of carcinogenesis. Each cell line has some unique characteristics, whether it arose directly from a carcinoma or resulted from immortalization with Simian virus 40 (SV40) or HPV, or was transformed in vitro by oncogenes. Comparisons of these characteristics should facilitate elucidation of the mechanisms involved in the initiation, promotion, and progression of prostate cancer. These cell lines will further serve as useful models for investigating tumor progression, invasion, metastasis, new therapeutic strategies, drug resistance, and its reversal and chemoprevention. The nontumorigenic cell lines were discussed in Part 1 [1]. This review summarizes the characteristics of several currently available tumorigenic, adult human prostatic epithelial cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018337     DOI: 10.1002/(sici)1097-0045(19970101)30:1<58::aid-pros9>3.0.co;2-h

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  27 in total

1.  Molecular characterization of human tensin.

Authors:  H Chen; A Ishii; W K Wong; L B Chen; S H Lo
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  In vitro and in vivo model systems used in prostate cancer research.

Authors:  David Cunningham; Zongbing You
Journal:  J Biol Methods       Date:  2015

Review 3.  The endocannabinoid system in prostate cancer.

Authors:  Inés Díaz-Laviada
Journal:  Nat Rev Urol       Date:  2011-09-13       Impact factor: 14.432

4.  Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration.

Authors:  Ji Wang; Robert F Place; Vera Huang; Xiaoling Wang; Emily J Noonan; Clara E Magyar; Jiaoti Huang; Long-Cheng Li
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

5.  Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker.

Authors:  Geng Zhang; Hongtao Zhang; Qiang Wang; Priti Lal; Ann M Carroll; Margarita de la Llera-Moya; Xiaowei Xu; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-18       Impact factor: 11.205

6.  Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes.

Authors:  Hari Krishnan Nair; Kesava V K Rao; Ravikumar Aalinkeel; Supriya Mahajan; Ram Chawda; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

7.  Detection of intracellular granularity induction in prostate cancer cell lines by small molecules using the HyperCyt high-throughput flow cytometry system.

Authors:  Mark K Haynes; J Jacob Strouse; Anna Waller; Andrei Leitao; Ramona F Curpan; Cristian Bologa; Tudor I Oprea; Eric R Prossnitz; Bruce S Edwards; Larry A Sklar; Todd A Thompson
Journal:  J Biomol Screen       Date:  2009-05-21

8.  DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

Authors:  Srinivasan Yegnasubramanian; Michael C Haffner; Yonggang Zhang; Bora Gurel; Toby C Cornish; Zhijin Wu; Rafael A Irizarry; James Morgan; Jessica Hicks; Theodore L DeWeese; William B Isaacs; G Steven Bova; Angelo M De Marzo; William G Nelson
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

9.  Role of protein kinase C-iota in transformed non-malignant RWPE-1 cells and androgen-independent prostate carcinoma DU-145 cells.

Authors:  H Y Win; M Acevedo-Duncan
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

10.  Physical and functional interaction of androgen receptor with calmodulin in prostate cancer cells.

Authors:  Eugenia Cifuentes; Jennifer M Mataraza; Barbara A Yoshida; Mani Menon; David B Sacks; Evelyn R Barrack; G Prem-Veer Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.